The pharmacology of AH8165: a rapid-acting, short-lasting, competitive neuromuscular blocking drug.
D000818:Animals; D001391:Azo Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002645:Chickens; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography; D005703:Gallamine Triethiodide / Q000494:pharmacology; D000882:Haplorhini; D007093:Imidazoles / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000633:toxicity; D008297:Male; D051379:Mice; D009132:Muscles / Q000187:drug effects; D009388:Neostigmine / Q000494:pharmacology; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D010197:Pancuronium / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects; D011726:Pyridinium Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D013390:Succinylcholine / Q000494:pharmacology; D013997:Time Factors
D001391:Azo Compounds; D007093:Imidazoles; D003473:Neuromuscular Nondepolarizing Agents; D011726:Pyridinium Compounds; D009388:Neostigmine; D013390:Succinylcholine; D010197:Pancuronium; D005703:Gallamine Triethiodide